vs
Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $7.1M, roughly 1.9× TECHPRECISION CORP). TECHPRECISION CORP runs the higher net margin — -20.8% vs -488.0%, a 467.2% gap on every dollar of revenue. On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -22.4%). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -9.2%).
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
OCUL vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $7.1M |
| Net Profit | $-64.7M | $-1.5M |
| Gross Margin | 88.0% | 5.4% |
| Operating Margin | -526.5% | -19.1% |
| Net Margin | -488.0% | -20.8% |
| Revenue YoY | -22.4% | -6.9% |
| Net Profit YoY | -33.6% | -84.4% |
| EPS (diluted) | $-0.27 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $7.1M | ||
| Q3 25 | $14.5M | $9.1M | ||
| Q2 25 | $13.5M | $7.4M | ||
| Q1 25 | $10.7M | $9.5M | ||
| Q4 24 | $17.1M | $7.6M | ||
| Q3 24 | $15.4M | $8.9M | ||
| Q2 24 | $16.4M | $8.0M | ||
| Q1 24 | $14.8M | $8.6M |
| Q4 25 | $-64.7M | $-1.5M | ||
| Q3 25 | $-69.4M | $825.0K | ||
| Q2 25 | $-67.8M | $-597.0K | ||
| Q1 25 | $-64.1M | $112.0K | ||
| Q4 24 | $-48.4M | $-799.0K | ||
| Q3 24 | $-36.5M | $-601.0K | ||
| Q2 24 | $-43.8M | $-1.5M | ||
| Q1 24 | $-64.8M | $-5.1M |
| Q4 25 | 88.0% | 5.4% | ||
| Q3 25 | 87.8% | 27.1% | ||
| Q2 25 | 85.6% | 14.0% | ||
| Q1 25 | 88.2% | 22.0% | ||
| Q4 24 | 92.8% | 13.0% | ||
| Q3 24 | 89.9% | 11.3% | ||
| Q2 24 | 90.8% | 3.0% | ||
| Q1 24 | 91.0% | 14.3% |
| Q4 25 | -526.5% | -19.1% | ||
| Q3 25 | -472.3% | 10.4% | ||
| Q2 25 | -502.6% | -6.3% | ||
| Q1 25 | -597.5% | 3.9% | ||
| Q4 24 | -296.1% | -9.1% | ||
| Q3 24 | -298.2% | -5.5% | ||
| Q2 24 | -265.1% | -16.8% | ||
| Q1 24 | -214.0% | -28.6% |
| Q4 25 | -488.0% | -20.8% | ||
| Q3 25 | -477.3% | 9.1% | ||
| Q2 25 | -503.9% | -8.1% | ||
| Q1 25 | -598.7% | 1.2% | ||
| Q4 24 | -283.3% | -10.5% | ||
| Q3 24 | -236.6% | -6.7% | ||
| Q2 24 | -266.3% | -18.3% | ||
| Q1 24 | -438.9% | -59.5% |
| Q4 25 | $-0.27 | $-0.15 | ||
| Q3 25 | $-0.38 | $0.08 | ||
| Q2 25 | $-0.39 | $-0.06 | ||
| Q1 25 | $-0.38 | $0.01 | ||
| Q4 24 | $-0.25 | $-0.08 | ||
| Q3 24 | $-0.22 | $-0.06 | ||
| Q2 24 | $-0.26 | $-0.16 | ||
| Q1 24 | $-0.49 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $737.1M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $654.3M | $8.0M |
| Total Assets | $808.1M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.1M | $50.0K | ||
| Q3 25 | $344.8M | $220.0K | ||
| Q2 25 | $391.1M | $143.0K | ||
| Q1 25 | $349.7M | $195.0K | ||
| Q4 24 | $392.1M | $165.0K | ||
| Q3 24 | $427.2M | $132.0K | ||
| Q2 24 | $459.7M | $44.8K | ||
| Q1 24 | $482.9M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $654.3M | $8.0M | ||
| Q3 25 | $258.2M | $9.1M | ||
| Q2 25 | $305.9M | $8.2M | ||
| Q1 25 | $265.9M | $8.7M | ||
| Q4 24 | $315.3M | $8.1M | ||
| Q3 24 | $352.0M | $8.9M | ||
| Q2 24 | $377.7M | $7.9M | ||
| Q1 24 | $408.0M | $7.8M |
| Q4 25 | $808.1M | $32.8M | ||
| Q3 25 | $410.9M | $33.8M | ||
| Q2 25 | $451.3M | $32.1M | ||
| Q1 25 | $405.9M | $33.5M | ||
| Q4 24 | $457.9M | $32.2M | ||
| Q3 24 | $490.4M | $35.0M | ||
| Q2 24 | $517.1M | $35.7M | ||
| Q1 24 | $538.9M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-54.2M | $183.0K |
| Free Cash FlowOCF − Capex | $-57.1M | $-827.0K |
| FCF MarginFCF / Revenue | -430.9% | -11.7% |
| Capex IntensityCapex / Revenue | 21.4% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-216.9M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-54.2M | $183.0K | ||
| Q3 25 | $-50.7M | $-1.1M | ||
| Q2 25 | $-55.2M | $646.0K | ||
| Q1 25 | $-44.7M | $396.0K | ||
| Q4 24 | $-39.4M | $-570.0K | ||
| Q3 24 | $-36.6M | $-532.0K | ||
| Q2 24 | $-24.8M | $107.0K | ||
| Q1 24 | $-33.9M | $-452.0K |
| Q4 25 | $-57.1M | $-827.0K | ||
| Q3 25 | $-56.7M | $-2.1M | ||
| Q2 25 | $-56.5M | $-604.0K | ||
| Q1 25 | $-46.6M | $-930.0K | ||
| Q4 24 | $-39.6M | $-1.7M | ||
| Q3 24 | $-36.6M | $-2.0M | ||
| Q2 24 | $-25.5M | $-94.0K | ||
| Q1 24 | $-34.1M | $-900.0K |
| Q4 25 | -430.9% | -11.7% | ||
| Q3 25 | -390.0% | -22.9% | ||
| Q2 25 | -419.7% | -8.2% | ||
| Q1 25 | -435.6% | -9.8% | ||
| Q4 24 | -232.0% | -22.9% | ||
| Q3 24 | -237.6% | -21.8% | ||
| Q2 24 | -155.4% | -1.2% | ||
| Q1 24 | -231.1% | -10.5% |
| Q4 25 | 21.4% | 14.2% | ||
| Q3 25 | 41.2% | 11.0% | ||
| Q2 25 | 9.3% | 16.9% | ||
| Q1 25 | 18.1% | 14.0% | ||
| Q4 24 | 1.2% | 15.4% | ||
| Q3 24 | 0.6% | 15.9% | ||
| Q2 24 | 4.5% | 2.5% | ||
| Q1 24 | 1.7% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OCUL
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
